Insider Transactions in Q3 2022 at Rvl Pharmaceuticals PLC (RVLP)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 10
2022
|
Alisa Lask Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+47.01%
|
-
|
|
Aug 08
2022
|
Avista Healthcare Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000,000
+25.21%
|
$8,000,000
$1.55 P/Share
|
|
Aug 08
2022
|
Sriram Venkataraman Director |
BUY
Open market or private purchase
|
Indirect |
8,000,000
+25.21%
|
$8,000,000
$1.55 P/Share
|
|
Aug 08
2022
|
David F Burgstahler Director |
BUY
Open market or private purchase
|
Indirect |
8,000,000
+25.21%
|
$8,000,000
$1.55 P/Share
|
|
Aug 08
2022
|
Brian A Markison Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
850,000
+22.22%
|
$850,000
$1.55 P/Share
|
|
Aug 08
2022
|
James Schaub EVP and COO |
BUY
Open market or private purchase
|
Direct |
150,000
+21.74%
|
$150,000
$1.55 P/Share
|